1. Peak Plasma Concentrations After Oral Morphine
SallyL Collins, BSc, ClaraC Faura, PhD, R.Andrew Moore, DSc, HenryJ McQuay, DM 
Journal of Pain and Symptom Management 
Volume 16, Issue 6, Pages (December 1998)
DOI: /S (98)

2. Fig. 1
Values for dose-corrected Cmax (left panel) and Tmax (right panel) for oral morphine by type of formulation (immediate-release, controlled-release, and once-daily). Black diamonds show the weighted mean values for each group. The size of the symbol is proportional to the number of subjects in the original study
Journal of Pain and Symptom Management  , DOI: ( /S (98) )

3. Fig. 2
Values for dose-corrected Cmax (left panel) and Tmax (right panel) for immediate-release and controlled-release oral morphine according to type of subject in the original study. Black diamonds show the weighted mean values for each group. The size of the symbol is proportional to the number of subjects in the original study
Journal of Pain and Symptom Management  , DOI: ( /S (98) )

4. Fig. 3
Values for dose-corrected Cmax (left panel) and Tmax (right panel) for immediate-release and controlled-release oral morphine according to dosing regimen and also showing type of subject in the original study. Black diamonds show the weighted mean values for each group. The size of the symbol is proportional to the number of subjects in the original study
Journal of Pain and Symptom Management  , DOI: ( /S (98) )

5. Fig. 4
Values for dose-corrected Cmax (left panel) and Tmax (right panel) for immediate-release oral morphine according to specific formulation and also showing type of subject in the original study. Black diamonds show the weighted mean values for each group. The size of the symbol is proportional to the number of subjects in the original study
Journal of Pain and Symptom Management  , DOI: ( /S (98) )

6. Fig. 5
Values for dose-corrected Cmax for controlled-release oral morphine according to brand. The results for multiple dose (upper panel) and those for single-dose studies (lower panel) are also divided according to type of subject (patients: white; healthy volunteers: gray). The size of the symbol is proportional to the number of subjects in the original study
Journal of Pain and Symptom Management  , DOI: ( /S (98) )

7. Fig. 6
Values for Tmax for controlled-release oral morphine according to brand. The results for multiple doses (upper panel) and those for single-dose studies (lower panel) are also divided according to type of subject (patients: white; healthy volunteers: gray). The size of the symbol is proportional to the number of subjects in the original study
Journal of Pain and Symptom Management  , DOI: ( /S (98) )

8. Fig. 7
Values for dose-corrected Cmax (left panel) and Tmax (right panel) for single doses of controlled-release and once-daily oral morphine in healthy volunteers according whether the subjects were fed or fasted. Black diamonds show the weighted mean values for each group. The size of the symbol is proportional to the number of subjects in the original study
Journal of Pain and Symptom Management  , DOI: ( /S (98) )

9. Fig. 8
Values for dose-corrected Cmax for immediate-release (left panel) and controlled-release (right panel) oral morphine according to whether the samples were analyzed by high performance liquid chromatography (HPLC), radioimmunoassay (RIA), or another method (Other). Black diamonds show the weighted mean values for each group. The size of the symbol is proportional to the number of subjects in the original study
Journal of Pain and Symptom Management  , DOI: ( /S (98) )